Biostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis | Taiwan News | Jul. 5, 2024 16:07
Jul 05, 2024 View Original Article
- Bias Rating
- Reliability
- Policy Leaning
- Politician Portrayal